中药复方联合西药治疗一例重症COVID-19病例
本文报告一例58岁女性重症COVID-19病例,中医辨证为气虚、湿瘀毒蕴,接受中药复方联合西药治疗。结论提示中西医协作对重症COVID-19患者管理有益。
要点
- 重症COVID-19可辨证为气虚、湿瘀毒蕴,采用中药复方联合西药治疗。
- 肺部CT病灶大部分吸收,未发现中药复方相关副作用。
核心结论
- 本病例报告提示中药联合西药协作治疗对重症COVID-19患者管理有益。
研究设计与样本
- 个案报告:一例58岁女性重症COVID-19患者,于2020年2月在贵州省人民医院住院。
主要发现
- 异常实验室指标及时恢复,肺部CT病灶大部分吸收。
- 未发现中药复方相关副作用。
- 出院前两次连续鼻咽拭子SARS-CoV-2检测阴性。
关键数值与推荐
- 中医辨证为气虚、湿瘀毒蕴。
- 接受中药复方联合西药治疗。
临床怎么用
- 中医与西医医生应在前线协作,为COVID-19重症患者提供优化照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Presentation of a case illustrating the benefits of traditional Chinese medicine (TCM) for treatment of Coronavirus disease 2019 (COVID-19) in critically ill patients. CLINICAL FEATURES AND OUTCOME: A 58-year-old woman presented with cough, fever, dizziness, chest tightness, polypnea and poor appetite. She was admitted to Guizhou Provincial People's hospital, and diagnosed with critically ill type of COVID-19 in February 2020. According to the patient's symptoms and signs, the TCM syndrome differentiation was qi deficiency, dampness-stasis and toxin accumulation. Then she received the combined therapy of a modified Chinese herbal formula and Western medicine. During a twelve-day period of treatment, her respiratory distress and appetite quickly improved. Abnormal laboratory indicators were resumed in time and lung lesions in CT scan largely absorbed. No side effects associated with this Chinese herbal formula were found. Before discharge, two consecutive nasopharyngeal swabs were shown to be negative for severe acute respiratory coronavirus 2 (SARS-CoV-2). CONCLUSIONS: Our case report suggests that collaborative treatments with traditional Chinese medicine prove beneficial in the management of COVID-19 in critically ill patients. In order to give optimal care for this COVID-19 crisis for the whole world, Chinese medicine practitioners and Western medical doctors should work together in frontline.
引用
- Zhang K, Tian M, Zeng Y, et al. The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19. Complement Ther Med. 2020. PMID: 32951723. doi:10.1016/j.ctim.2020.102473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。